Codes / ICD10CM / C72.1

C72.1 Malignant neoplasm of cauda equina

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of cauda equina

Summary

Malignant neoplasm of the cauda equina refers to cancerous growths originating in the bundle of nerve roots at the lower end of the spinal cord. These tumors can disrupt neurological function and require specialized medical evaluation and management.

Causes

The exact causes of malignant neoplasms in the cauda equina are not fully understood. Potential contributors include genetic mutations, environmental factors, or prior exposure to radiation. Some cases may arise from metastasis of cancers originating elsewhere in the body.

Risk Factors

  • Previous history of cancer, particularly those prone to metastasize to the nervous system.
  • Genetic predispositions or hereditary syndromes affecting nervous system tissues.
  • Exposure to certain carcinogens or radiation.
  • Age, with incidence often increasing in older adults.

Symptoms

  • Neurological deficits such as weakness, numbness, or paralysis in the lower extremities.
  • Pain localized to the lower back, buttocks, or legs.
  • Sensory disturbances, including tingling or loss of sensation in the legs or feet.
  • Impaired coordination, balance, or gait.
  • Changes in bowel or bladder function, including incontinence or retention.
  • Sexual dysfunction.

Diagnosis

Diagnosis typically involves a combination of clinical evaluation and imaging studies. Magnetic Resonance Imaging (MRI) is the primary tool for visualizing tumors in the cauda equina region. Additional tests may include computed tomography (CT) scans to assess bone involvement, and biopsy to determine the tumor type and grade. Neurological examinations help correlate symptoms with imaging findings.

Treatment Options

  • Surgery: To remove as much of the tumor as possible while preserving neurological function.
  • Radiation therapy: To target and destroy cancer cells, often used when complete surgical removal is not feasible.
  • Chemotherapy: For targeting cancer cells, particularly if the cancer is widespread or metastatic.
  • Corticosteroids: To reduce swelling and alleviate pressure on the nerves.

Prognosis and Follow-Up

Prognosis depends on factors such as tumor type, grade, and extent of spread. Early detection and treatment improve outcomes. Follow-up care includes regular imaging and neurological assessments to monitor for recurrence or progression. Long-term management may involve rehabilitation to address functional deficits.

Complications

  • Permanent neurological damage, including paralysis or sensory loss.
  • Bowel or bladder dysfunction.
  • Chronic pain.
  • Recurrence of the tumor.
  • Metastasis to other parts of the body.

Lifestyle & Prevention

  • Maintain a healthy lifestyle to support overall well-being.
  • Avoid known carcinogens and limit exposure to radiation.
  • Regular medical check-ups for individuals with risk factors.
  • Promptly address any new or worsening neurological symptoms.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden or severe neurological symptoms, such as loss of bowel or bladder control, severe weakness, or numbness in the legs. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

When coding for malignant neoplasm of the cauda equina (C72.1), ensure documentation supports the specific location and confirms malignancy. Verify that the diagnosis aligns with clinical findings and imaging results. Accurate coding requires clear differentiation from other spinal or nervous system neoplasms.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C72.1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.